Tonix Pharmaceuticals Holding Corp. Share Price Today: Live Updates & Key Insights
Tonix Pharmaceuticals Holding Corp. share price today is $15.05, up -4.88%. The stock opened at $15.72 against the previous close of $15.77, with an intraday high of $16.75 and low of $15.
Tonix Pharmaceuticals Holding Corp. Share Price Chart
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. Share Price Performance
Tonix Pharmaceuticals Holding Corp. Institutional Holdings
Tonix Pharmaceuticals Holding Corp. Market Status
Tonix Pharmaceuticals Holding Corp. Fundamentals
Market Cap 201.08 M
PB Ratio 0.8202
PE Ratio 0.0
Enterprise Value -5.25 M
Total Assets 277.17 M
Volume 1042945
Tonix Pharmaceuticals Holding Corp. Company Financials
About Tonix Pharmaceuticals Holding Corp. & investment objective
Company Information Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. In addition, the company develops TNX-102 SL, a cyclobenzaprine HCl sublingual tablet for the treatment of major depressive disorder and acute stress reaction/acute stress disorder; TNX-1300, a double-mutant cocaine esterase for the treatment of cocaine intoxication; TNX-1500, an Fc-modified humanized monoclonal antibody to prevent kidney transplant rejection, as well as to treat autoimmune conditions; TNX-4800, a humanized monoclonal antibody for the seasonal prevention of Lyme disease; and TNX-2900, an intranasal oxytocin potentiated with magnesium for the treatment of Prader-Willi syndrome. Further, it is developing TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, and arginine-vasopressin deficiency; TNX-801, a live horsepox vaccine for the prevention of smallpox and mpox; TNX-4200, a small molecule broad-spectrum antiviral agent targeting CD45 for the treatment or prevention of viral disease; TNX-4900, a highly selective small-molecule Sigma-1 receptor antagonist for neuropathic pain; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; and TNX-1800 and TNX-1850, live modified horsepox vaccines for the prevention of COVID. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in Berkeley Heights, New Jersey.
Organisation Biotechnology
Employees 142
Industry Biotechnology
CEO Dr. Seth Lederman M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Tonix Pharmaceuticals Holding Corp. FAQs
What is the share price of Tonix Pharmaceuticals Holding Corp. today?
The current share price of Tonix Pharmaceuticals Holding Corp. is $15.05.
Can I buy Tonix Pharmaceuticals Holding Corp. shares in India?
Yes, Indian investors can buy Tonix Pharmaceuticals Holding Corp. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Tonix Pharmaceuticals Holding Corp. shares in India?
You can easily invest in Tonix Pharmaceuticals Holding Corp. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Tonix Pharmaceuticals Holding Corp. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Tonix Pharmaceuticals Holding Corp..
Can I buy fractional shares of Tonix Pharmaceuticals Holding Corp.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp. has a market cap of $201.08 M.
In which sector does Tonix Pharmaceuticals Holding Corp. belong?
Tonix Pharmaceuticals Holding Corp. operates in the Biotechnology sector.
What documents are required to invest in Tonix Pharmaceuticals Holding Corp. stocks?
To invest, you typically need:
What is the PE and PB ratio of Tonix Pharmaceuticals Holding Corp.?
The PE ratio of Tonix Pharmaceuticals Holding Corp. is N/A and the PB ratio is 0.82.